188 related articles for article (PubMed ID: 2143889)
1. [A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate].
Tsumura I; Okamura Y; Takatsuka Y; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1509-12. PubMed ID: 2143889
[TBL] [Abstract][Full Text] [Related]
2. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
Satoh Y; Une Y; Fujisawa J; Uchino J
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
[TBL] [Abstract][Full Text] [Related]
3. [A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy].
Kanda K; Waki S; Uchimura M; Kida H; Narita K; Harada N
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2421-4. PubMed ID: 2260877
[TBL] [Abstract][Full Text] [Related]
4. [A case of breast cancer with metastasis of multiple organs showing marked efficacy of medroxyprogesterone acetate (MPA)].
Shimada K; Karaki Y; Ansai Y; Hino K; Yamashita Y; Fujimaki M
Gan To Kagaku Ryoho; 1996 Apr; 23(5):623-6. PubMed ID: 8678522
[TBL] [Abstract][Full Text] [Related]
5. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers].
Wada T; Matunami N; Houjou T; Morikawa E; Mori N; Nakano K; Aizawa M; Kurooka K; Kadota K; Yamato M
Gan To Kagaku Ryoho; 1989 May; 16(5):2087-92. PubMed ID: 2525004
[TBL] [Abstract][Full Text] [Related]
7. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
Nomura Y; Tashiro H; Hisamatsu K; Toi M
Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
[TBL] [Abstract][Full Text] [Related]
8. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
Lorenz I; Mechl Z
Neoplasma; 1985; 32(1):119-24. PubMed ID: 3157070
[TBL] [Abstract][Full Text] [Related]
9. [A case of advanced breast cancer with multiple organ metastases successfully treated by tamoxifen].
Shiba E; Kobayashi T; Takeda T; Miya A; Kawano I; Takai S; Mori T
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2255-8. PubMed ID: 1444494
[TBL] [Abstract][Full Text] [Related]
10. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Noguchi S; Yamamoto H; Inaii H; Koyama H
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of medroxyprogesterone acetate in advanced breast cancer].
Ueno K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ito Y; Imajo K; Ozeki H
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3198-202. PubMed ID: 2946264
[TBL] [Abstract][Full Text] [Related]
12. [A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Kusama M; Kaise H; Nakayama S; Oota D; Shimizu H; Aoki T; Koyanagi Y
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2243-7. PubMed ID: 11142170
[TBL] [Abstract][Full Text] [Related]
13. [Effect of medroxyprogesterone acetate on the cell kinetics in primary breast cancer].
Doihara H; Takashima S; Saeki H; Takiyama W; Kurita A; Soga H; Tanada M; Yokoyama N; Moriwaki S
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2057-62. PubMed ID: 2145805
[TBL] [Abstract][Full Text] [Related]
14. Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients.
Mallmann P; Dietrich K; Krebs D
Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):699-706. PubMed ID: 2151629
[TBL] [Abstract][Full Text] [Related]
15. [Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy].
Tominaga T
Gan No Rinsho; 1983 May; 29(6):628-31. PubMed ID: 6308307
[TBL] [Abstract][Full Text] [Related]
16. Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results.
Guarnieri A; Tucci E; D'Aniello C; Carli A; Mariani L; De Stefano A; Nardi P
Chemioterapia; 1984 Oct; 3(5):320-3. PubMed ID: 6241848
[TBL] [Abstract][Full Text] [Related]
17. [Value of hormone therapy in metastasizing breast cancer].
Samonigg H
Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
[TBL] [Abstract][Full Text] [Related]
18. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
[TBL] [Abstract][Full Text] [Related]
19. [A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy].
Yamada T; Okazaki M; Okazaki A; Sato H; Watanabe Y; Toda K; Okazaki Y; Asaishi K; Hirata K; Narimatsu E
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1923-5. PubMed ID: 1387777
[TBL] [Abstract][Full Text] [Related]
20. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]